M&G Alternatives Investment Management Ltd 13D/13G Filings for Barinthus Biotherapeutics plc (BRNS)

M&G Alternatives Investment Management Ltd 13D and 13G filings for Barinthus Biotherapeutics plc:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-01-19
08:27 am
Unchanged
2022-01-1913GBarinthus Biotherapeutics plc
BRNS
M&G Alternatives Investment Management Ltd4,108,752
11.970%
0
(Unchanged)
Filing
2021-11-05
1:33 pm
Purchase
2021-04-2913GBarinthus Biotherapeutics plc
BRNS
M&G Alternatives Investment Management Ltd4,108,752
11.970%
4,108,752increase
(New Position)
Filing